Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
109.50    2.00 (1.86%)
Bid:
105.50
Ask:
106.50
Spread: 1.00 (0.948%)
Market Cap: £107.91m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

AGM Trading Update

19 May 2016 07:00

RNS Number : 6543Y
Eurocell plc
19 May 2016
 

19th May 2016

 

Eurocell plc

AGM Trading Update and Director Appointment

 

Eurocell plc ("Eurocell" or the "Company"), the leading sustainable B2B supplier of PVC building products with its own distribution network, today provides a trading update for the first 20 weeks of the financial year to 13th May 2016.

Eurocell has had a positive start to the year with Group revenues up 16.3% to £69.8 million. Both the Profiles and the Building Plastics divisions delivered improved revenues on last year, with like for like sales in the branch network ahead by 11.8%, although in a very competitive market. There were 7 new branches opened during the period and the Company is on track to deliver 15 new sites in the current year as a whole. Both of the recent acquisitions, S & S Plastics and Vista Panels are delivering to expectations.

The UK RMI market conditions remain stable, and benefited from relatively mild weather in January and February. We have seen some movement in resin prices through ethylene increases, this has had limited impact to date.

We are also pleased to announce the appointment of Michael Scott as Chief Financial Officer on 1st September 2016. Michael is currently Head of Corporate Finance at Drax Group plc. He has been with Drax since 2005, having previously held the positions of Head of Investor Relations and Group Financial Controller. Michael also served as Interim Group Finance Director between May and December 2015. Prior to joining Drax, he worked for MT International and Arthur Andersen, where he qualified as a Chartered Accountant.

The half year results will be announced on 23 August 2016.

 

Bob Lawson, Chairman of Eurocell, commented:

"Eurocell has had a positive start to the year. We are delighted with today's appointment of Michael as CFO. He will bring considerable relevant experience particularly given his recent finance and IR roles at Drax. Alongside Mark, who is already making a positive impact as CEO, we have the right management team to further develop Eurocell from the strong platform they inherit. Overall, the business is positioned well and I am confident about our prospects for the future."

 

There are no further disclosures to be made on the appointment of Michael Scott pursuant to 9.6.13 of the Listing Rules

 

Further Enquiries:

Ben Foster, Camilla Cunningham 020 3603 5221

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAPMFTMBMBBBF
Date   Source Headline
1st Jun 20217:00 amRNSTotal Voting Rights
14th May 202111:18 amRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update – Strong First Four Months
12th May 20216:13 pmRNSDirector/PDMR Shareholding
4th May 20217:00 amRNSTotal Voting Rights
26th Apr 20219:40 amRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNSBlock Listing Application
16th Apr 20211:10 pmRNSAnnual Financial Report
16th Mar 20211:39 pmRNSInvestor Presentation
12th Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSBlock listing Interim Review
22nd Feb 202112:02 pmRNSNotice of Full Year Results Announcement
15th Jan 20217:00 amRNSYear End Trading Update – Strong Finish to 2020
12th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
1st Dec 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20203:00 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInvestor Presentation
17th Nov 20207:00 amRNSTrading Update – Improved Outlook
2nd Nov 20207:00 amRNSTotal Voting Rights
27th Oct 202011:23 amRNSHolding(s) in Company
15th Oct 202012:30 pmRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNSTotal Voting Rights
16th Sep 202012:20 pmRNSDirector/PDMR Shareholding
11th Sep 20207:00 amRNSDirector/PDMR Shareholding
7th Sep 202010:37 amRNSBlock listing Interim Review
4th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
2nd Sep 20209:59 amRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20209:59 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSTotal Voting Rights
8th Jul 20207:00 amRNSCOVID-19 and Trading Update
1st Jul 20209:34 amRNSTotal Voting Rights
30th Jun 20204:53 pmRNSNotice of Results
4th Jun 202011:47 amRNSDirector Declaration
26th May 20209:37 amRNSBlock Listing Application
19th May 20208:46 amRNSResult of AGM - Correction
15th May 202011:34 amRNSResult of AGM
14th May 20207:00 amRNSAGM and COVID-19 Update
30th Apr 20205:09 pmRNSHolding(s) in Company
17th Apr 202012:55 pmRNSAnnual Financial Report
16th Apr 20205:02 pmRNSHolding(s) in Company
14th Apr 20202:52 pmRNSDirector/PDMR Shareholding
7th Apr 20202:14 pmRNSHolding(s) in Company
3rd Apr 202012:13 pmRNSHolding(s) in Company
1st Apr 20203:22 pmRNSDirector/PDMR Shareholding
1st Apr 20203:21 pmRNSResult of Placing
1st Apr 202011:43 amRNSPlacing of Ordinary Shares
24th Mar 20202:44 pmRNSCOVID-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.